Trial Profile
Long-term Anastrozole versus Tamoxifen Treatment Effects in breast cancer: an epidemiologial observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Apr 2024
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Tamoxifen
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms LATTE
- 01 Jun 2017 Status changed from recruiting to completed.
- 10 Apr 2017 Planned End Date changed from 1 Oct 2015 to 21 Jan 2019.
- 04 Dec 2015 Accrual to date is 29% according to United Kingdom Clinical Research Network.